IP Library Granted Patent US 9,522,126
Granted Patent B2
US 9,522,126 · App. 14/597,017 · Granted Dec 20, 2016

Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists

Inventor: Roman Kelner (Northbrook, IL)
A61K31/137A61K9/0014A61K31/19A61K31/445A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,126
App. No.
14/597,017
Granted
Dec 20, 2016
Kind
B2
Abstract

The invention generally relates to methods of using adrenergic receptor agonists for the treatment of skin and mucosal superficial wounds. Some of the preferred adrenergic receptor agonists include epinephrine, phenylephrine, norepinephrine, methoxamine, and mixtures thereof. Methods according to the invention are especially effective to control superficial skin and mucosal bleeding and accelerate healing time.

Claims (9)

1. A method for the treatment of a superficial skin or a mucosal wound comprising topically applying to the skin or the mucosa a sterile aqueous composition comprising an effective amount of epinephrine.

2. The method of claim 1 , wherein said sterile aqueous composition comprises from about 0.001 mg/ml to about 2.5 mg/ml of epinephrine.

3. The method of claim 1 , wherein the skin or the mucosal wound is an abrasion or a cut.

4. The method of claim 1 , wherein the skin or the mucosal wound is a laceration.

5. The method of claim 1 , wherein said method inhibits blood flow in the local arteriolar-venal capillary nets.

6. The method of claim 1 , wherein said method results in shrinkage of the skin or the mucosa around said skin or said mucosal wound.

7. The method of claim 1 , wherein said sterile composition is applied using a disposable dispenser.

8. The method of claim 1 , wherein said sterile composition is applied using a disposable solution applicator.

9. The method of claim 1 , wherein the treatment results in the absence of a scab.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2024
From: KELNER, ROMAN, MD
To: BARRY JILIN 2021 LIVING TRUST
Reel/Frame 069268/0949 →
Continuity (2)
Division 12243689 · Oct 1, 2008
Related Publication 20150126556A1 · May 7, 2015